Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21865361 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Integrating the Genetic and Metabolic Faces of Obesity
Conditions: Insulin Resistance;   Obesity;   Metabolic Syndrome
Interventions: Behavioral: weight loss;   Drug: thiazolidinedione
2 Active, not recruiting Regional Fat Depots and Insulin Resistance
Conditions: Obesity;   Insulin Resistance;   Diabetes Mellitus Type 2

Indicates status has not been verified in more than two years